New York State Common Retirement Fund Protalix Bio Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

$75.2 Billion
Q2 2025

A detailed history of New York State Common Retirement Fund transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 69,000 shares of PLX stock, worth $164,220. This represents 0.0% of its overall portfolio holdings.

Number of Shares

69,000

Holding current value

$164,220

% of portfolio

0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$1.35 - $3.07 $93,150 - $211,830	69,000 New	69,000 $102,000
Q2 2024 Oct 08, 2025	SELL	$1.1 - $1.32 $75,289 - $90,347	-68,445 Reduced 99.2%	555 $0
Q2 2024 Jul 31, 2024	SELL	$1.1 - $1.32 $49,610 - $59,532	-45,100 Reduced 98.78%	555 $1,000
Q1 2024 Oct 08, 2025	SELL	$1.22 - $1.82 $28,480 - $42,487	-23,345 Reduced 33.83%	45,655 $57,000
Q1 2024 May 07, 2024	BUY	$1.22 - $1.82 $677 - $1,010	555 Added 1.23%	45,655 $58,000
Q4 2023 Oct 08, 2025	SELL	$1.34 - $1.85 $32,026 - $44,215	-23,900 Reduced 34.64%	45,100 $80,000
Q4 2023 Feb 01, 2024	SELL	$1.34 - $1.85 $938 - $1,295	-700 Reduced 1.53%	45,100 $80,000
Q3 2023 Oct 08, 2025	SELL	$1.49 - $2.02 $34,568 - $46,864	-23,200 Reduced 33.62%	45,800 $76,000
Q3 2023 Nov 07, 2023	BUY	$1.49 - $2.02 $1,043 - $1,414	700 Added 1.55%	45,800 $76,000
Q2 2023 Oct 08, 2025	SELL	$2.0 - $3.36 $47,800 - $80,304	-23,900 Reduced 34.64%	45,100 $90,000
Q2 2023 Aug 07, 2023	BUY	$2.0 - $3.36 $90,200 - $151,536	45,100 New	45,100 $90,000

Others Institutions Holding PLX

# of Institutions

Shares Held

8.67M

Call Options Held

168K

Put Options Held

31.4K

View Full List

About Protalix BioTherapeutics, Inc.

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $118M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

More about PLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Protalix Bio Therapeutics, Inc. Transaction History